BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34509920)

  • 21. Generation and characterization of six human induced pluripotent stem cell lines (iPSC) from three families with AP4M1-associated hereditary spastic paraplegia (SPG50).
    Eberhardt K; Jumo H; D'Amore A; Alecu JE; Ziegler M; Afshar Saber W; Sahin M; Ebrahimi-Fakhari D
    Stem Cell Res; 2021 May; 53():102335. PubMed ID: 34087981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of an induced pluripotent stem cell lines NSHDMUi001-A from patients with type 2 diabetes.
    Li P; Wang C; Wang J; Tan J; Liu Y; Lin Y
    Stem Cell Res; 2023 Jun; 69():103087. PubMed ID: 37028179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of iPSC lines from hereditary spastic paraplegia 56 (SPG56) patients and family members carrying CYP2U1 mutations.
    Leeson HC; Goh D; Coman D; Wolvetang EJ
    Stem Cell Res; 2022 Oct; 64():102917. PubMed ID: 36166872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells.
    Phang RZ; Tay FC; Goh SL; Lau CH; Zhu H; Tan WK; Liang Q; Chen C; Du S; Li Z; Tay JC; Wu C; Zeng J; Fan W; Toh HC; Wang S
    Stem Cells Transl Med; 2013 Dec; 2(12):935-45. PubMed ID: 24167318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of two induced pluripotent stem cell lines from a retinitis pigmentosa patient with compound heterozygous mutations in CRB1.
    Moon SY; Zhang D; Chen SC; Lamey TM; Thompson JA; McLaren TL; De Roach JN; Chen FK; McLenachan S
    Stem Cell Res; 2021 Jul; 54():102403. PubMed ID: 34034222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of twenty four induced pluripotent stem cell lines from twenty four members of the Lothian Birth Cohort 1936.
    Toombs J; Panther L; Ornelas L; Liu C; Gomez E; Martín-Ibáñez R; Cox SR; Ritchie SJ; Harris SE; Taylor A; Redmond P; Russ TC; Murphy L; Cooper JD; Burr K; Selvaraj BT; Browne C; Svendsen CN; Cowley SA; Deary IJ; Chandran S; Spires-Jones TL; Sareen D
    Stem Cell Res; 2020 Jul; 46():101851. PubMed ID: 32450543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of an induced pluripotent stem cell line (ZJUi007-A) from a 11-year-old patient of Fabry disease.
    Zhu Y; Zhang L; Wang G; Zhao J; Hou X; Wu H; Xu Y; Mao J; Liu Z; Zhang J
    Stem Cell Res; 2021 Aug; 55():102475. PubMed ID: 34365103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.A11.
    Hansen SK; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Stummann TC; Fog K; Hyttel P
    Stem Cell Res; 2016 May; 16(3):553-6. PubMed ID: 27346190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic regulation of human endogenous retroviruses mediates factor-induced reprogramming and differentiation potential.
    Ohnuki M; Tanabe K; Sutou K; Teramoto I; Sawamura Y; Narita M; Nakamura M; Tokunaga Y; Nakamura M; Watanabe A; Yamanaka S; Takahashi K
    Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12426-31. PubMed ID: 25097266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of an induced pluripotent stem cell line from a patient with Stargardt disease caused by biallelic c.[5461-10T>C;5603A>T];[6077T>C] mutations in the ABCA4 gene.
    Huang D; Zhang D; Chen SC; Thandar Aung-Htut M; Lamey TM; Thompson JA; McLaren TL; De Roach JN; Fletcher S; Wilton SD; McLenachan S; Chen FK
    Stem Cell Res; 2021 Jul; 54():102439. PubMed ID: 34214897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling Axonal Phenotypes with Human Pluripotent Stem Cells.
    Denton KR; Xu CC; Li XJ
    Methods Mol Biol; 2016; 1353():309-21. PubMed ID: 25520289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of two induced pluripotent stem cells lines from Mucopolysaccharydosis IIIA patient: IMEDEAi004-A and IMEDEAi004-B.
    Vallejo S; Fleischer A; Martín JM; Sánchez A; Palomino E; Bachiller D
    Stem Cell Res; 2018 Oct; 32():110-114. PubMed ID: 30269021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.B11.
    Hansen SK; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Stummann TC; Fog K; Hyttel P
    Stem Cell Res; 2016 May; 16(3):589-92. PubMed ID: 27346191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of a Crigler-Najjar Syndrome Type I patient-derived induced pluripotent stem cell line CNS705 (HHUUKDi005-A).
    Graffmann N; Martins S; Ljubikj T; Matte JC; Bohndorf M; Wruck W; Adjaye J
    Stem Cell Res; 2021 Mar; 51():102167. PubMed ID: 33485181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of induced pluripotent stem cell line (RCMGi001-A) from human skin fibroblasts of a cystic fibrosis patient with p.F508del mutation.
    Kondrateva E; Adilgereeva E; Amelina E; Tabakov V; Demchenko A; Ustinov K; Yasinovsky M; Voronina E; Lavrov A; Smirnikhina S
    Stem Cell Res; 2020 Oct; 48():101933. PubMed ID: 32777768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induced pluripotent stem cells from goat fibroblasts.
    Song H; Li H; Huang M; Xu D; Gu C; Wang Z; Dong F; Wang F
    Mol Reprod Dev; 2013 Dec; 80(12):1009-17. PubMed ID: 24123501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation.
    Zhang X; Moon SY; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; McLenachan S; Chen FK
    Stem Cell Res; 2019 May; 37():101452. PubMed ID: 31059986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of two induced pluripotent stem cell lines from a patient with recessive inherited retinal disease caused by compound heterozygous mutations in SNRNP200.
    Zhang D; McLenachan S; Chen SC; Zaw K; Alziyadat Y; Zhang X; Lamey TM; Thompson JA; McLaren TL; Mellough C; De Roach JN; Chen FK
    Stem Cell Res; 2021 Mar; 51():102154. PubMed ID: 33429167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of an induced pluripotent stem cell line, FJMUUHi001-A, from a hereditary Parkinson's disease patient with homozygous mutation of c.189dupA in PARK7.
    Chen ZT; Zhao ZH; Chen LN; Fan F; Cai GE; Weng HD; Wang YQ; Liao LM; Chen XC; Huang E; Ye QY
    Stem Cell Res; 2021 Mar; 51():102175. PubMed ID: 33485186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.